Page last updated: 2024-08-22

sizofiran and Colitis Gravis

sizofiran has been researched along with Colitis Gravis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, J; Hwang, J; Jang, K; Kim, YR; Koh, HJ; Lee, JD; Yang, CS	1

Other Studies

1 other study(ies) available for sizofiran and Colitis Gravis

Article	Year
The targeted delivery of the c-Src peptide complexed with schizophyllan to macrophages inhibits polymicrobial sepsis and ulcerative colitis in mice. Biomaterials, 2016, Volume: 89 Topics: Adjuvants, Immunologic; Amino Acid Sequence; Animals; Cell Line; Colitis, Ulcerative; Drug Delivery Systems; Female; HEK293 Cells; Humans; Macrophages; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oligopeptides; Reactive Oxygen Species; Sepsis; Sizofiran	2016

Article

Year

The targeted delivery of the c-Src peptide complexed with schizophyllan to macrophages inhibits polymicrobial sepsis and ulcerative colitis in mice.

Biomaterials, 2016, Volume: 89

Topics: Adjuvants, Immunologic; Amino Acid Sequence; Animals; Cell Line; Colitis, Ulcerative; Drug Delivery Systems; Female; HEK293 Cells; Humans; Macrophages; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oligopeptides; Reactive Oxygen Species; Sepsis; Sizofiran

2016